NICE director Falk reports stock option holdings

NICE Ltd. filed an initial Form 3 for director Dan Michael Falk, detailing his existing stock option holdings in the company’s ordinary shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

NICE Ltd. filed an initial Form 3 for director Dan Michael Falk, detailing his existing stock option holdings in the company’s ordinary shares. The filing lists multiple option awards with different exercise prices and expiration dates ranging from 2026 through 2031.

Some options, including grants covering ordinary shares at exercise prices such as 224.1800 and 144.9030, are fully vested and currently exercisable. One grant is already exercisable for 746 ordinary shares and is scheduled to vest in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant will fully vest on September 30, 2026. The form records holdings only and does not report new purchases or sales.

Insider Trade Summary

12 transactions reported

Mixed 12 txns

Insider Falk Dan Michael

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--

Holdings After Transaction: Options — 18,915 contracts (Direct)

Footnotes (3)

F1. The stock option is fully vested and currently exercisable.
F2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
F3. The stock option will vest on September 30, 2026.

FAQ

What does the NICE Ltd. (NCSYF) Form 3 for Dan Michael Falk report?

The Form 3 reports Dan Michael Falk’s existing stock option holdings in NICE Ltd. ordinary shares. It lists several option grants with specific exercise prices, expiration dates between 2026 and 2031, and notes which options are already vested or will vest on future dates.

Does the NICE Form 3 for Dan Michael Falk show any stock buys or sells?

No, this Form 3 only records existing stock option holdings for Dan Michael Falk. All entries are classified as holdings, with no reported purchases, sales, exercises, gifts, or tax-withholding dispositions in the summarized data for NICE Ltd. ordinary shares.

Which NICE Ltd. options held by Dan Michael Falk are fully vested and exercisable?

The filing states that at least one stock option is fully vested and currently exercisable. Specific examples include options over ordinary shares with exercise prices such as 224.1800 and 144.9030, each tied to defined expiration dates between 2026 and 2031.

How do Dan Michael Falk’s NICE options vest over time according to the Form 3?

One stock option is vested and exercisable for 746 ordinary shares and will vest for remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant is scheduled to vest fully on September 30, 2026.

What are the expiration dates of Dan Michael Falk’s NICE Ltd. stock options?

The reported option grants have expiration dates ranging from September 10, 2026, through September 30, 2031. Each option series in the filing is tied to a specific expiration date, defining how long Dan Michael Falk can choose to exercise those NICE ordinary share options.

What exercise prices are disclosed for Dan Michael Falk’s NICE stock options?

The Form 3 lists several exercise prices for the options over NICE ordinary shares, including amounts such as 224.1800, 232.2005, 197.4245, 168.4643, and 144.9030. Each price corresponds to a distinct option grant with its own vesting and expiration schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 09:04 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Falk Dan Michael

(Last)

(First)

(Middle)

221 RIVER STREET

(Street)

HOBOKEN

NEW JERSEY

07030

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

3a. Foreign Trading Symbol
[NICE.TA]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	09/10/2026	Ordinary Shares	2,785	$224.18	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	696	$0.2929	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	2,214	$232.2005	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	554	$0.3076	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	2,516	$197.4245	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	629	$0.2887	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	2,086	$206.5232	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	521	$0.2751	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	2,545	$168.4643	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	636	$0.2657	D
Options	⁽²⁾	09/30/2031	Ordinary Shares	2,987	$144.903	D
Options	⁽³⁾	09/30/2031	Ordinary Shares	746	$0.3025	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

3. The stock option will vest on September 30, 2026.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Alon Levy, Attorney-in-Fact for Dan Michael Falk	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR